Pharmacodynamic aspects of vitamins as adjuvant agents in the treatment of tuberculosis
https://doi.org/10.34680/2076-8052.2021.3(124).73-77
Abstract
Based on the developed classification (2020) of adjuvant agents in phthisiology, the authors herein investigate the presence and importance of vitamin pharmaceuticals; primarily, in terms of their pharmacodynamic qualities and their place in the overall plan of individualized host-directed therapy of the phthisiatric patient. Research targets also include polyhypovitaminosis in humans with tuberculosis (TB); likewise, the mutual influences of hypovitaminosis and the pro- and antioxidant balance in tuberculosis lesions; and questions related to the pharmacological action of vitamins C and D. The pharmacodynamic aspects of the use of vitamin agents for further clinical implementation in terms of enhancing the positive (and reducing the undesirable) effects of modern TB therapy are substantiated.
About the Authors
P. A. Gudz
Новгородский государственный университет имени Ярослава Мудрого
Russian Federation
Russian Federation
A. A. Kazanskaya
Новгородский государственный университет имени Ярослава Мудрого
Russian Federation
Russian Federation
A. R. Katsyna
Новгородский государственный университет имени Ярослава Мудрого
Russian Federation
Russian Federation
K. S. Khroutski
Новгородский государственный университет имени Ярослава Мудрого
Russian Federation
Russian Federation
References
1. Gudz' P.A., Semenov D.Yu., Seytov E.A., Khrutskiy K.S. Farmakologicheskiy obzor ad"yuvantnykh sredstv v sovremennoy ftiziatrii [Pharmacological review of adjuvant agents in modern phthisiology]. Vestnik NovSU, 2020, no.4 (120), pp. 60-69. DOI: https://doi.org/10.34680/2076-8052.2020.4(120).60-69
2. Tyul'kova T.E. Vliyanie piridoksina i preparatov gidrozida izonikotinovoy kisloty na nervnuyu sistemu pri lechenii tuberkuleza [The effect of pyridoxine and isonicotinic acid hydrozide preparations on the nervous system in the treatment of tuberculosis]. Tuberculosis and pulmonary diseases, 2018, vol. 96, no. 11, pp. 69-73. DOI: 10.21292/2075-1230-2018-96-11-69-73
3. Vasil'eva I.A. et al. Federal'nye klinicheskie rekomendatsii po diagnostike i lecheniyu tuberkuleza organov dykhaniya s mnozhestvennoy i shirokoy lekarstvennoy ustoychivost'yu vozbuditelya [Federal clinical guidelines for the diagnosis and treatment of multidrug-resistant and extensively drugresistant tuberculosis of the respiratory system]. Мoscow, 2015, 68 p.
4. Ftiziatriya. Natsional'nye klinicheskie rekomendatsii [Phthisiology. National clinical guidelines]. Moscow, GEOTAR-Media Publ., 2016, 240 p.
5. Brazhenko N.A., Brazhenko O.N. Tuberkulez: gomeostaz organizma i effektivnost' lecheniya [Tuberculosis: body homeostasis and treatment efficacy]. Saint Petersburg, SpetsLit Publ., 2017, 415 p.
6. Feshchenko Yu.I. Cheren'ko S.A., Mal'tsev V.I. et al. Otsenka znachimosti pobochnykh reaktsiy protivotuberkuleznykh preparatov pri lechenii tuberkuleza [Evaluation of significance of adverse reactions of antituberculosis drugs in treatment of tuberculosis]. Ukranian Medical Journal, 2008, no. 5, pp. 117-125.
7. Bakulina L.S., Pluzhnikov N.N., Isaev A.V. Algoritm issledovaniya prooksidantnoy sistemy organizma s tsel'yu vybora patogeneticheskoy farmakoterapii [Algorithm of pro-oxidant system of the body to select pathogenetic pharmacotherapy]. Sorbtsionnye i Khromatograficheskie Protsessy, 2018, vol.18, no.5, pp 766-775.
8. Gel'berg I.S., Vol'f S.B., Alekso E.N. et al. Narusheniya rezistentnosti, metabolizma pri tuberkuleze i metody patogeneticheskogo vozdeystviya v ego kompleksnom lechenii [Disorders of resistance, metabolism in tuberculosis and methods of pathogenetic action in its complex treatment]. Journal of the Grodno State Medical University, 2009, no.1, p.123-128.
9. Tyagi G., Singh P., Varma-Basil M. et al. Role of Vitamins B, C, and D in the fight against tuberculosis. Int J. Mycobacteriol, 2017, vol.6, pp.328-332.
10. Vilchèze C., Hartman T., Weinrick B. et al. Mycobacterium tuberculosis is extraordinarily sensitive to killing by a Vitamin Cinduced fenton reaction. Nat Commun., 2013, v.4, p.1881.
11. Mishra A, Sarkar D. Qualitative and quantitative proteomic analysis of Vitamin C induced changes in Mycobacterium smegmatis. Front. Microbiol., 2015, vol. 6, p.451.
12. Syal K., Bhardwaj N., Chatterji D. Vitamin C targets (p) ppGpp synthesis leading to stalling of long-term survival and biofilm formation in Mycobacterium smegmatis. FEMS Microbiol. Lett., 2017, vol.364, Fnw282.
13. Volchegorskiy I.A., Novoselov P.N., Astakhova T.V. Vliyanie askorbinovoy kisloty i emoksipina na effektivnost' kompleksnoy khimioterapii infil'trativnogo tuberkuleza legkikh [Effect of ascorbic acid and emoxipine on the efficacy of complex chemotherapy of infiltrative pulmonary tuberculosis]. Therapeutic Archive, 2009, vol.81, no.11, pp.21-24.
14. Khameneh B., Fazly Bazzaz B.S., Amani A. et al. Combination of anti-tuberculosis drugs with Vitamin C or NAC against different Staphylococcus aureus and Mycobacterium tuberculosis strains. Microb. Pathog., 2016, vol.93, pp.83-87.
15. Stroev Yu.I., Churilov L.P., Nikolaev A.V. Vitamin D, immune system and chronic infections. International Agroindustrial congress “Agrorus 2012. Innovations as the basis of modernization of agroindustrial complex”. Saint-Petersburg, August, 28-30, 2012. Saint Petersburg, 2012, pp. 154-156.
16. Gombart A.F., Borregaard N., Koeffler H.P. Human cathelicidin antimicrobial peptide (cAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvi-tamin D3. FASEB J., 2005, vol.19, pp. 1067-1077.
17. Chesney R.W. The Vitamin D and Magic Mountain: Antiinfective Role of the Vitamin. J. Pediat., 2010, vol.156, pp.698-703.
18. Liu P.T., Stenger S., Tang D.H. et al. Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J. Immunol., 2007, vol.179, pp.2060-2063.
19. Wang T-T., Nestel F. P., Bourdeau V. et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J. Immunol., 2004, vol.173, pp.2909-2912.
20. Liu P.T., Stenger S., Li H. et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science, 2006, vol.24, no.311(5768), pp.1770-1773.
21. Krutzik S.R., Hewison M., Liu P.T. et al. IL-15 links TLR2/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway. J. Immunol., 2008, vol.181, pp. 7115-7120.
22. Rockett K.A., Brookes R., Udalova I. et al. 1.25- Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line. Infect. Immun., 1998, vol. 66(11), pp.5314-5321.
23. Rodionov D.A., Mironov A.A., Gelfand M.S. Conservation of the biotin regulon and the BirA regulatory signal in Eubacteria and Archaea. Genome Res., 2002, vol.12, pp.1507-1516.
Review
For citations:
Gudz P.A., Kazanskaya A.A., Katsyna A.R., Khroutski K.S. Pharmacodynamic aspects of vitamins as adjuvant agents in the treatment of tuberculosis. Title in english. 2021;(3(124)):73-77. (In Russ.) https://doi.org/10.34680/2076-8052.2021.3(124).73-77
Views:
65
Email this article 